Thioredoxin reductase gene expression and activity among human T‐cell lymphotropic virus type 1–infected patients

Author(s):  
Neda Yaghoubi ◽  
Masoud Youssefi ◽  
Seyed Isaac Hashemy ◽  
Houshang Rafat Panah ◽  
Barat Ali Mashkani ◽  
...  
2006 ◽  
Vol 25 (5) ◽  
pp. 262-276 ◽  
Author(s):  
Jing Yao ◽  
Christian Grant ◽  
Edward Harhaj ◽  
Michael Nonnemacher ◽  
Timothy Alefantis ◽  
...  

2015 ◽  
Vol 89 (16) ◽  
pp. 8623-8631 ◽  
Author(s):  
Hei-Man Vincent Tang ◽  
Wei-Wei Gao ◽  
Chi-Ping Chan ◽  
Yun Cheng ◽  
Jian-Jun Deng ◽  
...  

ABSTRACTHuman T-cell leukemia virus type 1 (HTLV-1)-associated diseases are poorly treatable, and HTLV-1 vaccines are not available. High proviral load is one major risk factor for disease development. HTLV-1 encodes Tax oncoprotein, which activates transcription from viral long terminal repeats (LTR) and various types of cellular promoters. Counteracting Tax function might have prophylactic and therapeutic benefits. In this work, we report on the suppression of Tax activation of HTLV-1 LTR by SIRT1 deacetylase. The transcriptional activity of Tax on the LTR was largely ablated when SIRT1 was overexpressed, but Tax activation of NF-κB was unaffected. On the contrary, the activation of the LTR by Tax was boosted when SIRT1 was depleted. Treatment of cells with resveratrol shunted Tax activity in a SIRT1-dependent manner. The activation of SIRT1 in HTLV-1-transformed T cells by resveratrol potently inhibited HTLV-1 proviral transcription and Tax expression, whereas compromising SIRT1 by specific inhibitors augmented HTLV-1 mRNA expression. The administration of resveratrol also decreased the production of cell-free HTLV-1 virions from MT2 cells and the transmission of HTLV-1 from MT2 cells to uninfected Jurkat cells in coculture. SIRT1 associated with Tax in HTLV-1-transformed T cells. Treatment with resveratrol prevented the interaction of Tax with CREB and the recruitment of CREB, CRTC1, and p300 to Tax-responsive elements in the LTR. Our work demonstrates the negative regulatory function of SIRT1 in Tax activation of HTLV-1 transcription. Small-molecule activators of SIRT1 such as resveratrol might be considered new prophylactic and therapeutic agents in HTLV-1-associated diseases.IMPORTANCEHuman T-cell leukemia virus type 1 (HTLV-1) causes a highly lethal blood cancer or a chronic debilitating disease of the spinal cord. Treatments are unsatisfactory, and vaccines are not available. Disease progression is associated with robust expression of HTLV-1 genes. Suppressing HTLV-1 gene expression might have preventive and therapeutic benefits. It is therefore critical that host factors controlling HTLV-1 gene expression be identified and characterized. This work reveals a new host factor that suppresses HTLV-1 gene expression and a natural compound that activates this suppression. Our findings not only provide new knowledge of the host control of HTLV-1 gene expression but also suggest a new strategy of using natural compounds for prevention and treatment of HTLV-1-associated diseases.


1997 ◽  
Vol 16 (8) ◽  
pp. 782-791 ◽  
Author(s):  
Yasuhiro Sato ◽  
Kinji Ito ◽  
Takashi Moritoyo ◽  
Yujiro Fujino ◽  
Kanjiro Masuda ◽  
...  

1997 ◽  
Vol 71 (3) ◽  
pp. 1975-1983 ◽  
Author(s):  
I Lemasson ◽  
V Robert-Hebmann ◽  
S Hamaia ◽  
M Duc Dodon ◽  
L Gazzolo ◽  
...  

Author(s):  
Dislene Nascimento dos Santos ◽  
Katia Nunes Sá ◽  
Fernanda C. Queirós ◽  
Alaí Barbosa Paixão ◽  
Kionna Oliveira Bernardes Santos ◽  
...  

2011 ◽  
Vol 8 (1) ◽  
pp. 535 ◽  
Author(s):  
Walter K Neto ◽  
Antonio C Da-Costa ◽  
Ana Carolina S de Oliveira ◽  
Vanessa P Martinez ◽  
Youko Nukui ◽  
...  

2017 ◽  
Vol 55 (9) ◽  
pp. 2838-2849 ◽  
Author(s):  
Madoka Kuramitsu ◽  
Tsuyoshi Sekizuka ◽  
Tadanori Yamochi ◽  
Sanaz Firouzi ◽  
Tomoo Sato ◽  
...  

ABSTRACTWestern blotting (WB) for human T cell leukemia virus type 1 (HTLV-1) is performed to confirm anti-HTLV-1 antibodies detected at the initial screening of blood donors and in pregnant women. However, the frequent occurrence of indeterminate results is a problem with this test. We therefore assessed the cause of indeterminate WB results by analyzing HTLV-1 provirus genomic sequences. A quantitative PCR assay measuring HTLV-1 provirus in WB-indeterminate samples revealed that the median proviral load was approximately 100-fold lower than that of WB-positive samples (0.01 versus 0.71 copy/100 cells). Phylogenic analysis of the complete HTLV-1 genomes of WB-indeterminate samples did not identify any specific phylogenetic groups. When we analyzed the nucleotide changes in 19 HTLV-1 isolates from WB-indeterminate samples, we identified 135 single nucleotide substitutions, composed of four types, G to A (29%), C to T (19%), T to C (19%), and A to G (16%). In the most frequent G-to-A substitution, 64% occurred at GG dinucleotides, indicating that APOBEC3G is responsible for mutagenesis in WB-indeterminate samples. Moreover, interestingly, five WB-indeterminate isolates had nonsense mutations in Pol and/or Tax, Env, p12, and p30. These findings suggest that WB-indeterminate carriers have low production of viral antigens because of a combination of a low proviral load and mutations in the provirus, which may interfere with host recognition of HTLV-1 antigens.


Sign in / Sign up

Export Citation Format

Share Document